Items where Author is "Ashby, Deborah"

Item Type No Grouping

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody lateral flow assay for antibody prevalence studies following vaccination:a diagnostic accuracy study. (2022) Cann, Alexandra and Cooke, Graham S. and Clarke, Candice and Brown, Jonathan and Thomson, Tina and Prendecki, Maria and Moshe, Maya and Badhan, Anjna and Simmons, Bryony and Klaber, Bob and Elliott, Paul and Darzi, Ara and Riley, Steven and Ashby, Deborah and Martin, Paul and Gleeson, Sarah and Willicombe, Michelle and Kelleher, Peter and Ward, Helen and Barclay, Wendy S. picture_as_pdf

Balancing benefit and risk of medicines: a systematic review and classification of available methodologies. Mt-Isa, Shahrul and Hallgreen, Christine E. and Wang, Nan and Callréus, Torbjörn and Genov, Georgy and Hirsch, Ian and Hobbiger, Stephen F. and Hockley, Kimberley S. and Luciani, Davide and Phillips, Lawrence D. and Quartey, George and Sarac, Sinan B. and Stoeckert, Isabelle and Tzoulaki, Ioanna and Micaleff, Alain and Ashby, Deborah

Financial incentives to improve adherence to anti-psychotic maintenance medication in non-adherent patients: a cluster randomised controlled trial (FIAT). Priebe, Stefan and Burton, Alexandra and Ashby, Deborah and Ashcroft, Richard E. and Burns, Tom and David, Anthony and Eldridge, Sandra and Firn, Mike and Knapp, Martin and McCabe, Rose

IMI-PROTECT benefit-risk grouprecommendations report:recommendations for the methodology andvisualisation techniques to be used in theassessment of benefit and risk of medicines. Hughes, Diana and Waddingham, Ed, A., J. and Mt-Isa, Shahrul and Goginsky, Alesia and Chan, Edmond and Downey, Gerald and Hallgreen, Christine E. and Hockley, Kimberley S. and Juhaeri, Juhaeri and Lieftucht, Alfons and Metcalfe, Marilyn, A. and Noel, Rebecca, A. and Phillips, Lawrence D. and Ashby, Deborah and Micaleff, Alain

Literature review of visual representation of the results of benefit–risk assessments of medicinal products. Hughes, David and Talbot, S. and Mt-Isa, S. and Lieftucht, Alfons and Phillips, L.D. and Asiimwe, Alex and Hallgreen, C. E. and Downey, G. and Genov, G. and Hermann, Richard and Metcalf, M.A. and Noel, R.A. and Tzoulaki, I. and Ashby, Deborah and Micaleff, Alain

Recommendations for benefit–risk assessment methodologies and visual representations. Hughes, David and Waddingham, E. and Mt-Isa, S. and Goginsky, Alesia and Chan, Edmond and Downey, Gerald and Hallgreen, C. E. and Hockley, K.S. and Juhaeri, J. and Lieftucht, Alfons and Metcalf, M.A. and Noel, R.A. and Phillips, L.D. and Ashby, Deborah and Micaleff, Alain

Review of visualisation methods for therepresentation of benefit-risk assessment ofmedication: Stage 1 of 2. Mt-Isa, Shahrul and Peters, Ruth and Phillips, Lawrence D. and Chan, Kakit and Hockley, Kimberley S. and Wang, Nan and Ashby, Deborah and Tzoulak, Ioanna

Review of visualisation methods for therepresentation of benefit-risk assessment ofmedication: stage 2 of 2. Mt-Isa, Shahrul and Hallgreen, Christine, E. and Asiimwe, Alex and Downey, Gerry and Genov, Georgy and Hermann, Richard and Hughes, Diana and Lieftucht, Alfons and Noel, Rebecca and Peters, Ruth and Phillips, Lawrence D. and Shepherd, Susan and Micaleff, Alain and Ashby, Deborah and Tzoulak, Ioanna